China
Africa
Explore chapters and articles related to this topic
Inventory Resources and Risks for Recovery
Published in Sandra Rasmussen, Developing Competencies for Recovery, 2023
This is not a geographical cure. My name is Deborah H; I am a single 33-year-old software engineer. I am alcohol and drug-free for four years. My Bipolar I disorder is managed effectively. I received a job promotion and am moving cross-country with my parent company. I found an in-network psychiatrist who kept me on Abilify. I am now met with a mental health counselor to continue my overall recovery work. Together we reviewed my personal assets and liabilities. I have four years continuous recovery and reasonable stability of my bipolar disorder. I am highly motivated to grow in my recovery. Even though I planned the move and “feel ready” for the change, we identified personal, professional, and social stress and risks to manage. My apartment complex has a gym and pool. I am walking distance from a temple. I plan to participate in online recovery meetings until I am more comfortable around the city. The counselor suggested a focus on self-care and work as priority goals: “keep it simple.” I scheduled sessions with the mental health counselor every two weeks for the next three months. I am cautiously optimistic about me, my recovery, and my future.
Meta-Analysis with Binary Data
Published in Ding-Geng (Din) Chen, Karl E. Peace, Applied Meta-Analysis with R and Stata, 2021
Ding-Geng (Din) Chen, Karl E. Peace
Bipolar disorder is a psychiatric condition historically known as manic-depressive disorder. Bipolar disorder is among the top causes of worldwide disability and is characterized by both depressive and manic episodes as described in Geddes et al. (2009). Bipolar disorder is a lifelong recurrent illness and there is no known cure. Patients usually require long-term treatment with psychotherapy drugs to control symptoms. Lamotrigine is one of several drugs used in the treatment of bipolar disorder. It is an anticonvulsant and has been approved by the US FDA as an adjunctive treatment for epilepsy and for maintenance treatment for Bipolar I disorder. Lamotrigine is marketed in the USA and in some European countries as “Lamictal” by GlaxoSmithKline.
Bipolar Disorder in Children and Young People
Published in Cathy Laver-Bradbury, Margaret J.J. Thompson, Christopher Gale, Christine M. Hooper, Child and Adolescent Mental Health, 2021
It is currently thought, based on available evidence, that bipolar disorder is a chronic and, at times, disabling condition with poor rates of remission (Ferrari et al., 2016). However, with the right combination of treatment, it is possible for people to experience periods of stability, and studies have shown that approximately one-third of people diagnosed can experience euthymic mood up to 80% of the time (Birmaher, 2017).
Comparing the efficacy of aripiprazole as an add-on to valproate with other second-generation antipsychotics in acute mania symptoms in manic patients in Iran
Published in International Journal of Psychiatry in Clinical Practice, 2022
Zeinab Sadat Ayatollahi, Mehran Shayganfard, Hamidreza Jamilian, Anita Alaghmand
A person with bipolar disorder has severe mood swings. This fluctuation usually lasts for weeks or months which is completely different from mood changes that occur normally in daily life. These patients have mainly three pathological moods: severe depression; mania; and mixed mood (defined as depression along with hyperactivity due to mania) (Benazzi 2007). Patients with type 1 bipolar disorder experience at least one period of mania for a week. Although most of the patients have depression periods too, some of them experience only mania. Manic episodes can last between 3 and 6 months without treatment. Depression episodes will last 6–12 months if are left untreated (Treuer and Tohen 2010). The aetiology of these disorders is not fully understood, however, research has indicated that bipolar disorder is inherited. In other words, genes are more effective than the environment. Moreover, researchers hypothesised that these disorders may result from a physical problem in a brain area that controls our mood. Additionally, mood swings can sometimes be caused by stress (Miklowitz and Johnson 2006; Arnold et al. 2021).
Effect of long acting injectable antipsychotics on course and hospitalizations in bipolar disorder – a naturalistic mirror image study
Published in Nordic Journal of Psychiatry, 2022
Eren Yıldızhan, Eda Uzun, Nesrin Buket Tomruk
In our naturalistic study from a CMHC, considering the results from the patients with bipolar disorder who were on maintenance treatment with an LAI antipsychotic, we conclude that addition of LAI treatment could have a positive effect on the frequency and duration of hospitalizations in selected patients. Prospective studies that also takes into consideration the drop out cases are necessary to find the criteria for eligibility for successful treatment with an LAI antipsychotic. Studies with larger cohorts may answer if there is difference for generic type of LAI antipsychotics in terms of the effect on psychiatric hospitalizations. In addition, although reducing the hospitalizations is an important result, there are still unmet needs in the treatment of bipolar disorder, especially in the area of personal and social functioning.
Cognitive Stabilization Intervention during the Era of COVID-19
Published in Developmental Neuropsychology, 2021
Margaret Lanca, Danielle N. Abrams, Persephone Crittenden, Kelly M. Jones
Cognitive training for psychiatric disorders has been shown to have positive effects. For example, patients with MDD who underwent cognitive training tended to show improvements in attention, working memory, and overall cognitive functioning with large effect sizes, with additional evidence of improvement in depression symptoms (Keshavan, Vinogradov, Rumsey, Sherrill, & Wagner, 2014; Motter et al., 2016) and everyday functioning (Motter et al., 2016). Some suggest that cognitive training may work by activating the prefrontal cortex and by identifying compensatory strategies to manage cognitive impairment, particularly in those with MDD (Porter et al., 2013) and ADHD (Keshavan et al., 2014). Functional remediation, psychoeducation, training for daily life, and stress management strategies, may be particularly important for treatment of bipolar disorder (Bowie et al., 2013; Gitlin & Miklowitz, 2017; Martínez-Arán et al., 2011).